Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma

Molecular and Cellular Proteomics

Volumn 12, Issue 11, 2013, Pages 3271-3284

  Yan, Ming ^a   Yang, Xihu ^a   Wang, Lizhen ^a   Clark, David ^b   Zuo, Hui ^b   Ye, Dongxia ^a   Chen, Wantao ^a   Zhang, Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA6 INTEGRIN; BETA1 INTEGRIN; BETA4 INTEGRIN; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; CD104 ANTIGEN; CD71 ANTIGEN; CD98 ANTIGEN; CELL ADHESION MOLECULE; CELL MEMBRANE PROTEIN; CELL SURFACE MARKER; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELL ADHESION MOLECULE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HERMES ANTIGEN; INTEGRIN; NESTIN; NOMO1 PROTEIN; SOLUTE CARRIER FAMILY 3A2; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR NANOG; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ADHERENT CELL; ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER STEM CELL; CANCER TRANSPLANTATION; CARCINOGENESIS; CARCINOGENICITY; CELL CULTURE; CELL MEMBRANE; CELL POPULATION; CELL SELECTION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM; FEMALE; FLOW CYTOMETRY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIP CARCINOMA; LYMPH NODE METASTASIS; MALE; MOUSE; MOUTH CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; SMOKING; TANDEM MASS SPECTROMETRY; TONGUE CARCINOMA; TUMOR RECURRENCE; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

ADULT; AGED; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES, NEURONAL; CELL LINE, TUMOR; CELL MEMBRANE; FEMALE; FETAL PROTEINS; HEAD AND NECK NEOPLASMS; HETEROGRAFTS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASTIC STEM CELLS; PROGNOSIS; PROTEOMICS; SPHEROIDS, CELLULAR; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 84887076843     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.025460     Document Type: Article

References (42)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin. 61, 69-90.
2. Jordan, C. T., Guzman, M. L., and Noble, M. (2006) Cancer stem cells. N. Engl. J. Med. 355, 1253-1261. (Pubitemid 44427449)
3. Bonnet, D., and Dick, J. E. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737. (Pubitemid 27298715)
4. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., and Clarke, M. F. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 3983-3988. (Pubitemid 36418143)
5. Prince, M. E., Sivanandan, R., Kaczorowski, A., Wolf, G. T., Kaplan, M. J., Dalerba, P., Weissman, I. L., Clarke, M. F., and Ailles, L. E. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 104, 973-978. (Pubitemid 46154721)
6. Clevers, H. (2011) The cancer stem cell: premises, promises and challenges. Nat. Med. 17, 313-319.
7. Quintana, E., Shackleton, M., Foster, H. R., Fullen, D. R., Sabel, M. S., Johnson, T. M., and Morrison, S. J. (2010) Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18, 510-523.
8. Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P. J., Aigner, L., Brawanski, A., Bogdahn, U., and Beier, C. P. (2007) CD133 and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 67, 4010-4015. (Pubitemid 46815044)
9. Pece, S., Tosoni, D., Confalonieri, S., Mazzarol, G., Vecchi, M., Ronzoni, S., Bernard, L., Viale, G., Pelicci, P. G., and Di Fiore, P. P. (2010) Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140, 62-73.
10. Prokhorova, T. A., Rigbolt, K. T., Johansen, P. T., Henningsen, J., Kratchmarova, I., Kassem, M., and Blagoev, B. (2009) Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells. Mol. Cell. Proteomics 8, 959-970.
11. Gu, B., Zhang, J., Wu, Y., Zhang, X., Tan, Z., Lin, Y., Huang, X., Chen, L., Yao, K., and Zhang, M. (2011) Proteomic analyses reveal common promiscuous patterns of cell surface proteins on human embryonic stem cells and sperms. PLoS One 6, e19386.
12. Gao, Q., Qiu, S. J., Fan, J., Zhou, J., Wang, X. Y., Xiao, Y. S., Xu, Y., Li, Y. W., and Tang, Z. Y. (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 25, 2586-2593. (Pubitemid 47041232)
13. Leth-Larsen, R., Lund, R., Hansen, H. V., Laenkholm, A. V., Tarin, D., Jensen, O. N., and Ditzel, H. J. (2009) Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol. Cell. Proteomics 8, 1436-1449.
14. van Houdt, W. J., Emmink, B. L., Pham, T. V., Piersma, S. R., Verheem, A., Vries, R., Fratantoni, S. A., Pronk, A., Clevers, H., Borel Rinkes, I. H., Jimenez, C. R., and Kranenburg, O. (2011) Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target. Mol. Cell. Proteomics 10, 011353.
15. Ben-Porath, I., Thomson, M. W., Carey, V. J., Ge, R., Bell, G. W., Regev, A., and Weinberg, R. A. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499-507. (Pubitemid 351601215)
16. Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., and Clevers, H. (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611.
17. Mack, B., and Gires, O. (2008) CD44s and CD44v6 expression in head and neck epithelia. PLoS One 3, e3360.
18. Chen, C., Wei, Y., Hummel, M., Hoffmann, T. K., Gross, M., Kaufmann, A. M., and Albers, A. E. (2011) Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 6, e16466.
19. Arai, K., Shibahara, T., Yamamoto, N., and Noma, H. (2002) The presence of candidate tumor suppressor gene loci at chromosome 3p for oral squamous cell carcinomas. Oral Oncol. 38, 763-771. (Pubitemid 36254704)
20. Chen, N., Hudson, J. E., Walczak, P., Misiuta, I., Garbuzova-Davis, S., Jiang, L., Sanchez-Ramos, J., Sanberg, P. R., Zigova, T., and Willing, A. E. (2005) Human umbilical cord blood progenitors: The potential of these hematopoietic cells to become neural. Stem Cells 23, 1560-1570. (Pubitemid 41741005)
21. Sato, C., Matsuda, T., and Kitajima, K. (2002) Neuronal differentiation-dependent expression of the disialic acid epitope on CD166 and its involvement in neurite formation in Neuro2A cells. J. Biol. Chem. 277, 45299-45305. (Pubitemid 36159136)
22. Alsalameh, S., Amin, R., Gemba, T., and Lotz, M. (2004) Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum. 50, 1522-1532. (Pubitemid 38608074)
23. Fujiwara, H., Tatsumi, K., Kosaka, K., Sato, Y., Higuchi, T., Yoshioka, S., Maeda, M., Ueda, M., and Fujii, S. (2003) Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166). J. Clin. Endocrinol. Metab. 88, 3437-3443. (Pubitemid 36877526)
24. Wiiger, M. T., Gehrken, H. B., Fodstad, O., Maelandsmo, G. M., and Andersson, Y. (2010) A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth. Cancer Immunol. Immunother. 59, 1665-1674.
25. Swart, G. W., Lunter, P. C., Kilsdonk, J. W., and Kempen, L. C. (2005) Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration? Cancer Metastasis Rev. 24, 223-236. (Pubitemid 40922796)
26. Klein, W. M., Wu, B. P., Zhao, S., Wu, H., Klein-Szanto, A. J., and Tahan, S. R. (2007) Increased expression of stem cell markers in malignant melanoma. Mod. Pathol. 20, 102-107. (Pubitemid 44967955)
27. Kristiansen, G., Pilarsky, C., Wissmann, C., Stephan, C., Weissbach, L., Loy, V., Loening, S., Dietel, M., and Rosenthal, A. (2003) ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate 54, 34-43. (Pubitemid 36043834)
28. Kristiansen, G., Pilarsky, C., Wissmann, C., Kaiser, S., Bruemmendorf, T., Roepcke, S., Dahl, E., Hinzmann, B., Specht, T., Pervan, J., Stephan, C., Loening, S., Dietel, M., and Rosenthal, A. (2005) Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J. Pathol. 205, 359-376. (Pubitemid 40253926)
29. Mezzanzanica, D., Fabbi, M., Bagnoli, M., Staurengo, S., Losa, M., Balladore, E., Alberti, P., Lusa, L., Ditto, A., Ferrini, S., Pierotti, M. A., Barbareschi, M., Pilotti, S., and Canevari, S. (2008) Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients. Clin. Cancer Res. 14, 1726-1733. (Pubitemid 351469457)
30. Ihnen, M., Kilic, E., Kohler, N., Loning, T., Witzel, I., Hagel, C., Holler, S., Kersten, J. F., Muller, V., Janicke, F., and Milde-Langosch, K. (2011) Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin. J. Clin. Pathol. 64, 146-152.
31. Davies, S., and Jiang, W. G. (2010) ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis. Anticancer Res. 30, 1163-1168.
32. King, J. A., Ofori-Acquah, S. F., Stevens, T., Al-Mehdi, A. B., Fodstad, O., and Jiang, W. G. (2004) Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res. 6, R478-R487.
33. Levin, T. G., Powell, A. E., Davies, P. S., Silk, A. D., Dismuke, A. D., Anderson, E. C., Swain, J. R., and Wong, M. H. (2010) Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract. Gastroenterology 139, 2072-2082.
34. Dalerba, P., Dylla, S. J., Park, I. K., Liu, R., Wang, X., Cho, R. W., Hoey, T., Gurney, A., Huang, E. H., Simeone, D. M., Shelton, A. A., Parmiani, G., Castelli, C., and Clarke, M. F. (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. U.S.A. 104, 10158-10163. (Pubitemid 47175279)
35. Tachezy, M., Effenberger, K., Zander, H., Minner, S., Gebauer, F., Vashist, Y. K., Sauter, G., Pantel, K., Izbicki, J. R., and Bockhorn, M. (2011) ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients. Int. J. Cancer 131, 396-405.
36. Kahlert, C., Weber, H., Mogler, C., Bergmann, F., Schirmacher, P., Kenngott, H. G., Matterne, U., Mollberg, N., Rahbari, N. N., Hinz, U., Koch, M., Aigner, M., and Weitz, J. (2009) Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. Br. J. Cancer 101, 457-464.
37. Hong, X., Michalski, C. W., Kong, B., Zhang, W., Raggi, M. C., Sauliunaite, D., De Oliveira, T., Friess, H., and Kleeff, J. (2010) ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer. J. Surg. Oncol. 101, 564-569.
38. Kulasingam, V., and Diamandis, E. P. (2007) Proteomics analysis of conditioned media from three breast cancer cell lines: A mine for biomarkers and therapeutic targets. Mol. Cell. Proteomics 6, 1997-2011. (Pubitemid 350201873)
39. Kulasingam, V., Zheng, Y., Soosaipillai, A., Leon, A. E., Gion, M., and Diamandis, E. P. (2009) Activated leukocyte cell adhesion molecule: A novel biomarker for breast cancer. Int. J. Cancer 125, 9-14.
40. van den Brand, M., Takes, R. P., Blokpoel-deRuyter, M., Slootweg, P. J., and van Kempen, L. C. (2010) Activated leukocyte cell adhesion molecule expression predicts lymph node metastasis in oral squamous cell carcinoma. Oral Oncol. 46, 393-398.
41. Verma, A., Shukla, N. K., Deo, S. V., Gupta, S. D., and Ralhan, R. (2005) MEMD/ALCAM: A potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology 68, 462-470. (Pubitemid 41160978)
42. Sawhney, M., Matta, A., Macha, M. A., Kaur, J., Datta-Gupta, S., Shukla, N. K., and Ralhan, R. (2009) Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients. Int. J. Cancer 124, 2098-2105.